Martin Currie Ltd. Purchases 1,139 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Martin Currie Ltd. raised its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 54.5% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 3,228 shares of the medical equipment provider's stock after purchasing an additional 1,139 shares during the quarter. Martin Currie Ltd.'s holdings in Intuitive Surgical were worth $1,685,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently made changes to their positions in the company. Atala Financial Inc purchased a new stake in Intuitive Surgical in the fourth quarter worth $25,000. Berbice Capital Management LLC purchased a new stake in shares of Intuitive Surgical in the 4th quarter worth about $26,000. BankPlus Trust Department bought a new position in shares of Intuitive Surgical in the 4th quarter worth about $28,000. Summit Securities Group LLC purchased a new position in Intuitive Surgical during the 4th quarter valued at about $30,000. Finally, Kohmann Bosshard Financial Services LLC bought a new stake in Intuitive Surgical during the fourth quarter worth about $31,000. Institutional investors own 83.64% of the company's stock.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on ISRG shares. Jefferies Financial Group boosted their price target on Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. Barclays increased their price objective on shares of Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. Evercore ISI raised their price target on shares of Intuitive Surgical from $490.00 to $530.00 in a research report on Monday, January 27th. Morgan Stanley raised Intuitive Surgical from an "equal weight" rating to an "overweight" rating and lifted their price objective for the stock from $522.00 to $650.00 in a report on Monday, December 2nd. Finally, UBS Group upped their price target on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a "neutral" rating in a research report on Monday, January 27th. One analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $611.86.

Remove Ads

Insider Buying and Selling at Intuitive Surgical

In related news, Director Amal M. Johnson sold 4,635 shares of the firm's stock in a transaction on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the transaction, the director now directly owns 12,275 shares of the company's stock, valued at approximately $6,955,015. This trade represents a 27.41 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Robert Desantis sold 11,545 shares of Intuitive Surgical stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the completion of the transaction, the executive vice president now directly owns 5,224 shares of the company's stock, valued at $2,607,925.28. The trade was a 68.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 33,754 shares of company stock worth $17,691,621. Insiders own 0.70% of the company's stock.

Intuitive Surgical Stock Performance

Shares of Intuitive Surgical stock traded up $1.09 on Tuesday, hitting $496.36. 1,609,268 shares of the company traded hands, compared to its average volume of 1,531,879. The business has a 50-day simple moving average of $554.33 and a 200 day simple moving average of $532.98. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00. The stock has a market capitalization of $176.79 billion, a P/E ratio of 77.44, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.